BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32839279)

  • 1. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Dickinson JA
    J Am Soc Nephrol; 2020 Sep; 31(9):1931-1940. PubMed ID: 32839279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Kidney Disease in Low- and Middle-Income Countries.
    Kalyesubula R; Conroy AL; Calice-Silva V; Kumar V; Onu U; Batte A; Kaze FF; Fabian J; Ulasi I
    Semin Nephrol; 2022 Sep; 42(5):151315. PubMed ID: 37001337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Tiv S; Anand S; Mohan D; Garcia Garcia G; Gutiérrez Padilla JA; Klarenbach S; Navarro Blackaller G; Seck S; Wang J; Zhang L; Muntner P
    JAMA Netw Open; 2021 Oct; 4(10):e2127396. PubMed ID: 34605917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of screening for Chronic Kidney Disease.
    Djukanović Lj
    Prilozi; 2010; 31(1):249-59. PubMed ID: 20693945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
    George C; Echouffo-Tcheugui JB; Jaar BG; Okpechi IG; Kengne AP
    BMC Med; 2022 Aug; 20(1):247. PubMed ID: 35915501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention programs for chronic kidney disease in low-income countries.
    Perico N; Remuzzi G
    Intern Emerg Med; 2016 Apr; 11(3):385-9. PubMed ID: 26983956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Kidney Disease.
    Webster AC; Nagler EV; Morton RL; Masson P
    Lancet; 2017 Mar; 389(10075):1238-1252. PubMed ID: 27887750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.
    Gheewala PA; Zaidi STR; Jose MD; Bereznicki L; Peterson GM; Castelino RL
    J Nephrol; 2018 Feb; 31(1):27-36. PubMed ID: 28181150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.
    Okpechi IG; Caskey FJ; Gaipov A; Tannor EK; Hamonic LN; Ashuntantang G; Donner JA; Figueiredo A; Inagi R; Madero M; Malik C; Moorthy M; Pecoits-Filho R; Tesar V; Levin A; Jha V
    BMJ Open; 2021 Dec; 11(12):e053857. PubMed ID: 34916325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine reporting of estimated glomerular filtration rate (eGFR) in African laboratories and the need for its increased utilisation in clinical practice.
    Adebisi SA
    Niger Postgrad Med J; 2013 Mar; 20(1):57-62. PubMed ID: 23661212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighborhood Socioeconomic Status and Identification of Patients With CKD Using Electronic Health Records.
    Ghazi L; Oakes JM; MacLehose RF; Luepker RV; Osypuk TL; Drawz PE
    Am J Kidney Dis; 2021 Jul; 78(1):57-65.e1. PubMed ID: 33359151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
    George C; Mogueo A; Okpechi I; Echouffo-Tcheugui JB; Kengne AP
    BMJ Glob Health; 2017; 2(2):e000256. PubMed ID: 29081996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Oct; 157(8):567-70. PubMed ID: 22928170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.
    Flood D; Garcia P; Douglas K; Hawkins J; Rohloff P
    BMJ Open; 2018 Jan; 8(1):e019778. PubMed ID: 29358450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.
    McEwan P; Hafner M; Jha V; Correa-Rotter R; Chernin G; De Nicola L; Villanueva R; Wheeler DC; Barone S; Nolan S; Garcia Sanchez JJ
    J Med Econ; 2023; 26(1):1407-1416. PubMed ID: 37807895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary interventions for adults with chronic kidney disease.
    Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study.
    van Mil D; Kieneker LM; Evers-Roeten B; Thelen MHM; de Vries H; Hemmelder MH; Dorgelo A; van Etten RW; Heerspink HJL; Gansevoort RT
    Lancet; 2023 Sep; 402(10407):1052-1064. PubMed ID: 37597522
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.